Deutsche Bank Defends TCF Financial (TCB); Sell-Off Overdone on Credit Concerns
Get Alerts TCB Hot Sheet
Price: $16.86 -0.65%
Rating Summary:
3 Buy, 15 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
3 Buy, 15 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Deutsche Bank maintains a 'Buy' on TCF Financial (NYSE: TCB).
Deutsche analyst said, "TCB shares are off sharply this morning—likely due to concerns over credit. However, credit quality continues to be lumpy at TCF (charge-offs were down sharply in 1Q for example) and other trends should be viewed as a relief—ie service charges rebounded off very low levels, NIM was above mgmt guidance, and deposits (ex a deal) rose slightly. And while another change is coming to TCF’s deposit account offering which will be earnings dilutive in 2H12, it looks likely to be earnings neutral and deposit accretive in 2013."
For an analyst ratings summary and ratings history on TCF Financial click here. For more ratings news on TCF Financial click here.
Shares of TCF Financial closed at $11.42 yesterday.
Deutsche analyst said, "TCB shares are off sharply this morning—likely due to concerns over credit. However, credit quality continues to be lumpy at TCF (charge-offs were down sharply in 1Q for example) and other trends should be viewed as a relief—ie service charges rebounded off very low levels, NIM was above mgmt guidance, and deposits (ex a deal) rose slightly. And while another change is coming to TCF’s deposit account offering which will be earnings dilutive in 2H12, it looks likely to be earnings neutral and deposit accretive in 2013."
For an analyst ratings summary and ratings history on TCF Financial click here. For more ratings news on TCF Financial click here.
Shares of TCF Financial closed at $11.42 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
- Movano (MOVE) Misses Q2 EPS by 195c
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Deutsche Bank, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share